In the area of drug delivery, New Directions Technology Consulting is the exclusive market developer for the mMed patent portfolio, which is offered for sale or licensing. Medication telemanagement systems based on the portfolio can be used to develop innovative health and wellness programs that can benefit a wide spectrum of stakeholders.
Healthcare products to diagnose and treat are increasingly going directly into patients' hands. This is especially the case with expensive and sensitive specialty pharma products, which often are genetically engineered proteins that must be injected.
Greater patient engagement using medication telemanagement can result in better health outcomes and reduced costs, while presenting huge opportunities for Pharma and other stakeholders at the technology forefront of the evolving healthcare market.